Seems like just bill selling but the buyer pressure wasn't there to counteract it, still see potential in the fundamental business model tho. May buy tomorrow depending on closing price
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025